Tag: Prescription Drugs
Persistent Use Higher With New Generation Beta-Blockers
Notable improvement seen with carvedilol and nebivolol, but not betaxolol
Antipsychotic Polypharmacy Has Prevalence of 12 Percent
Diagnosis of schizophrenia, length of stay of 90 days or more are strongest predictors of polypharmacy
Buprenorphine May Be Helpful in Peripheral Neuropathic Pain
When tolerated, buprenorphine is effective for DPNP, but many patients withdrew from study
Drug Shows Promise for Genetic Proopiomelanocortin Deficiency
After 10 months of daily treatment, one patient lost 112 lbs; another lost 45 lbs in three months
Diabetes Meds Deemed Equal, but Metformin Still First-Line
No significant differences in risk of cardiovascular or all-cause mortality
Biologic Response Modifier Use in Kids Ups Infectious Complications
Risk varies with class of BRM; increased risk of mycobacterial, viral, fungal, opportunistic infections
Early Initiation of ART Cuts HIV-1 Infection in Partners
Risk of genetically-linked partner infection 93 percent lower with early antiretroviral therapy
Metamizole Could Be Alternative to Classical NSAIDs
Fewer gastric, duodenal ulcers with metamizole; limited risk of bleeding in post-op pain management
Small HIV Infection Risk in Condomless Sex With Use of ART
Study suggests transmission risk is low if infected person adheres to antiretroviral treatment
Nilotinib Shows Early Promise for Parkinson’s Disease
Medication generally found safe, and study findings hint at a benefit
